SNDL Inc.
Health
Performance
8.7
Risk
Sell
Buy
Curious about the Scores? Learn more.

SNDL Inc. stock rating and score history

All changes in ratings, performance and outlook tracked over time.

23.12.2025
Rock bottom. The fall’s complete, stability nowhere to be found.
18.12.2025
Momentum tanked. Clearly underperforming.
16.12.2025
Red alert. Risk levels out of control.
20.08.2025
Pulse detected. Still fragile, but stabilizing.

SNDL Inc. stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does SNDL Inc. do? Business model and key facts

Get the full picture of SNDL Inc.: what it builds, where it operates, and how it makes money.

SNDL Inc. Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 2604

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Cannabis Operations and Retail Operations segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use markets; and private sale of recreational cannabis through corporate owned and franchised retail cannabis stores. The company also produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

shop
Company facts
Zachary Ryan George
CEO
2604
Employees worldwide
shop
Performance
-7.51%
Last 12 months
-73.38%
Last 5 years
shop
Growth
$920,45M
Revenue year
$-96.204.000
Net income
shop
Valuation
$412,00M
Market Cap
-7.18
Price/Earnings Ratio

Stocks related to SNDL Inc.

Selected based on industry alignment and relative market positioning.

SIGA
SIGA Technologies, Inc.
6.82
+0.44%
8.3
Sell
Buy
SIGA Technologies, Inc.
ORGO
Organogenesis Holdings Inc.
3.99
+1.01%
9.4
Sell
Buy
Organogenesis Holdings Inc.
KMDA
Kamada Ltd.
8.87
+3.62%
2.9
Sell
Buy
Kamada Ltd.
LFCR
Lifecore Biomedical, Inc.
8.67
-1.70%
5.3
Sell
Buy
Lifecore Biomedical, Inc.
EOLS
Evolus, Inc.
4.95
+2.70%
8.5
Sell
Buy
Evolus, Inc.

SNDL Inc. fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.